Manufacture of prefilled syringes

Information

  • Patent Grant
  • 6189195
  • Patent Number
    6,189,195
  • Date Filed
    Tuesday, August 22, 1995
    29 years ago
  • Date Issued
    Tuesday, February 20, 2001
    24 years ago
Abstract
This invention relates to a process for manufacturing prefilled syringes where at least one of the syringe components is manufactured in at least a class 100 environment. The process includes the steps of manufacturing syringe components, such as the barrel and plunger substrate, within at least a class 100 and MCB-3 environment; manufacturing syringe components, such as the plunger cover and tip seal in an environment less clean than a class 100 environment; decontaminating the plunger cover and tip seal; lubricating at least one of the barrel, plunger substrate, plunger cover and tip seal; assembling the barrel and tip seal to form a barrel/tip seal combination; assembling the plunger cover and plunger substrate to form a plunger; filling the barrel/tip seal combination with a predetermined amount of fluid; and final assembling of the prefilled syringe by inserting the plunger into the barrel/tip seal combination. When the syringe components are manufactured at different locations, each component is tripled-bagged to maintain the component substantially free from contaminants, and transported to an assembly site where the components are unpackaged and assembled into the barrel/tip seal combination and plunger. When filling and final assembly of the barrel/tip seal combination takes place at a location separate from its assembly site, the barrel/tip seal combination is tripled-bagged to maintain it substantially free from contaminants, and transported to a filling and final assembling site for filling and final assembling into a prefilled syringe.
Description




TECHNICAL FIELD OF THE INVENTION




This invention relates in general to manufacturing processes for syringes, and more particularly to manufacturing processes for syringes prefilled with a fluid, such as a diagnostic contrast media or drug, where at least one of the syringe components is manufactured in at least a class 100 environment.




BACKGROUND OF THE INVENTION




Prefilled syringes provide convenience of use by eliminating the need to load the syringe with a fluid, such as contrast media, and by minimizing the need to purge air. Manufacturing processes for prefilled syringes are known in the art. For example, processes are known for producing prefilled, sterile glass syringes whereby the manufactured syringe components are washed and sterilized prior to partial assembly. The partially assembled glass syringe is filled with a fluid, sealed with a plunger, and sterilized once again by heating. U.S. Pat. Nos. 4,718,463 and 4,628,969, both issued to Jurgens, Jr. et al., teach a process for manufacturing plastic, prefilled syringes using repeated water jet washing of the syringe components prior to assembly and filling. Water washing is expensive because it requires ultra-purified water. Water washing is also troublesome because it is difficult to inspect and insure satisfactory cleaning. Therefore, it is desirable to reduce the number of washing steps required in the manufacture of prefilled syringes. Further, prior art syringe manufacturing processes do not provide precautionary steps to maintain syringe components substantially free from contaminants, such as viable and nonviable particles, during molding, assembly and filling. Therefore, it is desirable to develop a method for manufacturing prefilled syringes which substantially reduces viable and nonviable particles that may contaminate the syringe components during molding, assembly and filling.




SUMMARY OF THE INVENTION




This invention relates to a process for manufacturing prefilled syringes which reduces the number of component washing steps and permits the molding, assembly and filling of components substantially free of contaminants. A typical syringe which can be manufactured by the process of the invention includes a barrel, plunger substrate, plunger cover and tip seal.




In general the process begins by molding the barrel and plunger substrate from non-elastomeric material, such as polypropylene, polycarbonate or other medical grade plastic, within at least a class 100 environment. A class 100 environment, as used herein, is defined as an environment having no more than 100 viable or nonviable particles per cubic foot of air, 0.5 microns and larger. Further, this manufacturing environment should be at least a MCB-3 environment. A MCB-3 environment, as used herein, is defined as an environment wherein the microbial level of gram positive microorganisms is less than 3 cfu (colony forming unit) per cubic foot of air, and the microbial level of gram negative microorganisms is less than 1 cfu per cubic foot of air.




The molding temperature for the barrel and plunger substrate may be selected such that it renders these components substantially sterile and substantially free from contaminants. Any contaminants, such as particulate matter, that may exist in the air within the class 100 environment proximate to the components after molding may be removed from the class 100 environment by air flow. Thus, the barrel and plunger substrate manufactured under these conditions need not be washed.




The plunger cover and tip seal are molded from an elastomeric material, such as rubber, by any suitable molding method such as compression molding. As it is typically more difficult to compression mold these components within a class 100 environment due to the procedures and materials used, these components are manufactured in an environment less clean than a class 100 environment. Specifically, compression molded components are typically formed from a large sheet of rubber material. After the rubber has vulcanized in the mold, the entire sheet of molded components is removed from the mold and trimmed. The trimming process generates particulate matter from the cutoffs and lubrication that is used. Any contaminants that may exist on the plunger cover or tip seal after molding are removed by any suitable method, such as the use of ultrasonic or jet washing with freon or ultra-purified water, otherwise referred to as water-for-injection. The plunger cover and tip seal are then transferred to a class 100 environment.




After molding and contaminant removal, the plunger cover and tip seal are lubricated with silicone oil, hereinafter referred to as “silicone”, to facilitate the assembly of the plunger cover onto the plunger substrate to form the plunger, and the assembly of the tip seal to the distal end of the barrel to form the barrel/tip seal combination. The plunger cover and tip seal may also require sterilization by any suitable method, such as use of ethylene oxide or autoclaving. After assembly of the plunger and the barrel/tip seal combination within at least a class 100 and MCB-3 environment, the barrel/tip seal combination is filled with a fluid, such as a contrast medium or drug, and the plunger is inserted therein to complete the assembly of the prefilled syringe.




Oftentimes different manufacturing steps take place at different locations. In this instance, it is desirable to package the components or partially assembled components in packaging that will maintain the components or partially assembled components substantially free from contaminants while being transported from one manufacturing location to another. In a preferred embodiment of the invention, the components or partially assembled components within at least a class 100 environment are “triple-bagged” to prevent contamination. Specifically, the components or partially assembled components are inserted into separate first and second containers, such as plastic bags, which are sealed to prevent entry of contamination. The packaged components or partially assembled components are then transferred to an environment less clean than a class 100 environment, such as a class 10,000 environment, where they are placed in a third container, such as a plastic bag, which is sealed to prevent entry of contaminants. A class 10,000 environment, as used herein, is defined as an environment having no more than 10,000 viable or nonviable particles per cubic foot of air, 0.5 microns and larger. The third bag is then placed in a shipping box for delivery to the next manufacturing location.




Upon arrival at the next manufacturing location, the shipping box is placed in an environment less clean than a class 100 environment, such as a class 10,000 environment. The packaged components or partially assembled components are then removed from the box and third bag, and placed in a feedthrough box connected to at least a class 100 environment, where they are removed from the second bag. The second bag remains in the feedthrough box, and the first bag containing the packaged components or partially assembled components is transported to into the class 100 environment. The packaged components or partially assembled components are removed from the first bag and set up for further manufacturing steps. It is understood that the components and partially assembled components can be transferred to any number of manufacturing locations by using the packaging and unpackaging procedures of the present invention.




In the manufacturing process of the invention, a salient technical advantage is that the number of washing steps required by the prior art is substantially reduced and the syringe components are molded, assembled and filled substantially free from contaminants.











BRIEF DESCRIPTION OF THE DRAWINGS





FIG. 1

is an axial sectional view of a representative syringe which may be manufactured according a syringe manufacturing process of the invention;





FIGS. 2



a


and


2




b


together comprise a flow diagram of a syringe manufacturing process according to a first embodiment of the invention;





FIGS. 3-5

are schematic block diagrams showing successive steps in a filling and final syringe assembly procedure according to a syringe manufacturing process of the invention;





FIGS. 6



a


and


6




b


together comprise a flow diagram of a syringe manufacturing process according to a second embodiment of the invention;





FIG. 7

is a schematic diagram showing successive steps in a packaging process according to the invention; and





FIG. 8

is a process flow diagram showing steps in an unpackaging process according to the invention.











DETAILED DESCRIPTION




The manufacturing process of the invention may be used to manufacture a syringe, such as syringe


10


shown in FIG.


1


. Syringe


10


comprises several components including a barrel


12


having a cylindrically-shaped body


14


and a tapered nozzle section


16


joined together by a tapered conical section


18


. Tip


20


of nozzle section


16


forms the distal end of syringe


10


. Flange


22


is located on the body


14


at the proximal end of barrel


12


to secure syringe


10


within an injector pressure jacket (not shown), such as the pressure jacket described in U.S. Pat. No. 4,677,980. Alternatively, syringe


10


may include mounting flanges (not shown) at its proximal end and to facilitate attachment to a front-loading injector, as described in U.S. Pat. No. 5,383,858.




Syringe


10


further comprises a plunger


24


which is sealingly engaged within the body


14


. Plunger


24


typically includes a plunger substrate


26


and legs


28


extending therefrom to engage the drive piston (not shown) of the injector (not shown). Plunger


24


may further include a plunger cover


30


attached to the plunger substrate


26


. Alternatively, plunger


24


may be made of a single piece including legs


28


. Tip seal


32


having an interior surface


34


is attached to syringe tip


20


by any suitable means, such as friction or screw threads (not shown). Typically, the barrel


12


and plunger substrate


26


are manufactured from a non-elastomeric material, such as polypropylene and polycarbonate, respectively, and the plunger cover


30


and tip seal are manufactured from an elastomeric material, such as rubber. For details considering the structure and operation of syringe


10


, reference is made to U.S. Pat. Nos. 4,677,980 and 5,383,858 assigned to the common assignee of this application. These patents are fully incorporated herein by reference for their description of syringes and injectors. When syringe


10


is manufactured with a predetermined amount of fluid


36


contained within barrel


12


, the syringe is referred to as a “prefilled syringe.”




The first embodiment of the process invention is demonstrated in the flow diagram of

FIGS. 2



a


and


2




b


. In this embodiment, all of the manufacturing activities for syringe


10


are performed within the same manufacturing location. With respect to barrel


12


, plastic pellets for barrel


12


are received at step


210


, inspected at step


212


and staged at step


214


. Barrel


12


is molded at step


216


within at least a class 100 environment, at a temperature sufficient to render barrel


12


substantially free from contaminants. The manufacturing environment should also be at least a MCB-3 environment. Any particulate matter that may exist in the air proximate to the barrel


12


after the molding process is diverted away from barrel


12


by any suitable means, such as air flow. Thus, barrel


12


need not be decontaminated or otherwise washed. Barrel


12


is inspected at step


218


and its inside surface is lubricated with any suitable lubrication means, such as silicone, at step


220


. Lubrication is required because barrel


12


receives plunger


24


having a rubber cover


30


.




The raw material for tip seal


32


is received at step


222


. The molding compound for tip seal


32


is formulated at step


224


, tested and inspected at step


226


, and staged at step


228


. Tip seal


32


is molded out of the compound at step


230


in an environment less clean than a class 100 environment and is inspected at step


232


. Contaminants on the tip seal


32


surface are then removed at step


234


by any suitable method, such as the use of ultrasonic or jet washing with freon or ultra-purified water. After contaminant removal, tip seal


32


is maintained in at least a class 100 environment at step


236


and lubricated at step


238


with any suitable lubrication means, such as silicone. It is understood that tip seal


32


may also be lubricated while being decontaminated at step


234


. Tip seal


32


may also be sterilized at step


239


, by any suitable sterilization method, such as use of ethylene oxide or autoclaving. Barrel


12


and tip seal


32


are then assembled at step


240


to form a barrel/tip seal combination.




Non-elastomeric material, such as polypropylene pellets, is received for the plunger substrate


26


at step


242


, inspected at step


244


and staged at step


246


. Similar to barrel


12


, plunger substrate


26


is molded at step


248


in at least a class 100 environment at a temperature sufficient to render the plunger substrate


26


substantially free from contaminants. The manufacturing environment should also be at least a MCB-3 environment. Any particulate matter that may exist in the air proximate to the plunger substrate


26


after the molding process is diverted away from plunger substrate


26


by any suitable means, such as air flow. Thus, the plunger substrate


26


need not be decontaminated or otherwise washed. Plunger substrate


26


is then inspected at step


250


.




Elastomeric material, such as rubber, for the plunger cover


30


is received at step


252


. The molding compound for the plunger cover


30


is formulated at step


254


, tested and inspected at step


256


and staged at step


258


. Plunger cover


30


is molded from the molding compound at step


260


in an environment less clean than a class 100 environment and inspected at step


262


. Any contaminants that may exist on the surface of the plunger cover


30


are then removed by any suitable method at step


264


, such as using ultrasonic or jet washing with freon or ultra-purified water. Plunger cover


30


is then maintained in at least a class 100 environment at step


265


and lubricated at step


266


by any suitable lubrication means, such as silicone. It is understood that plunger cover


30


may also be lubricated while being decontaminated at step


264


. As with tip seal


32


, plunger cover


30


may also be sterilized at step


267


by any suitable method. Plunger cover


30


and plunger substrate


26


are assembled at step


268


.




As shown in

FIG. 2



b


, the fluid


36


, such as contrast medium, for filling the prefillable syringe


10


, is staged at step


268


, made up at step


270


, placed in a holding tank at step


272


and tested at step


274


. The barrel/tip seal combination is then filled with the fluid


36


by any suitable filling method at step


276


and plunger


24


is then inserted into the filled barrel/tip seal combination at step


278


.





FIGS. 3-5

show the progressive stages of a preferred method for filling the barrel/tip seal combination, identified by reference numeral


38


. As demonstrated in

FIG. 3

, the barrel/tip seal combination


38


and plunger


24


are placed inside of a hermetic enclosure


300


located within a clean environment, preferably at least a class 100 and MCB-3 environment. Filling tube


310


for introducing fluid


36


into the barrel/tip seal combination


38


also extends into the enclosure


300


. Barrel/tip seal combination


38


and plunger


24


are held in place by appropriate retaining means, such as clamps or the like (not shown). Class 100 air within the enclosure


300


is then evacuated.




As shown in

FIG. 4

, filling tube


310


is used to inject fluid


36


, such as a contrast medium, into the proximal end of the barrel/tip seal combination


38


. Prior to filling, fluid


36


is staged according to the manufacturing process described in accordance with

FIGS. 2



a


and


2




b


. After a predetermined level of fluid


36


is injected into the barrel/tip seal combination


38


, fluid flow through tube


310


is terminated.




After the barrel/tip seal combination


38


is filled with fluid


38


, plunger


24


is moved by an articulable arm (not shown) or the like and inserted into the barrel/tip seal combination


38


. The outside surface of the plunger


24


forms a hermetic seal with the interior sidewalls of the barrel/tip seal combination


38


. Class 100 air is then reintroduced into enclosure


300


and the completely assembled, prefilled syringe


10


is removed therefrom. The process is then repeated for each subsequent barrel/tip seal combination


38


and plunger


24


. It is understood that suitable machinery can be designed to perform this filling and final assembly step on a plurality of barrel/tip seal combinations


38


and plungers


24


at the same time.




The filling process described herein prohibits air from entering into barrel/tip seal combination


38


, which would be medically undesirable. Tip seal


32


located at the distal end of syringe


10


and plunger


24


located near the proximal end of syringe


10


provide, in combination with the sidewalls of the syringe


10


, a hermetic seal to contain the injectable fluid


36


. The filling and final assembly process results in a prefilled, sterile syringe


10


which subsequently can be speedily mounted onto an injector head (not shown) by the user. A technical advantage is provided in that the user need not fill the syringe


10


through the tip


20


, but can proceed directly to a fluid injection procedure.




Referring back to

FIG. 2



b


, the completed prefilled syringe


10


, which may be placed in a protective pouch, is then sterilized at step


280


by any suitable method, such as autoclaving, labeled at step


282


, and inspected at step


284


. A prefilled syringe


10


that does not meet predetermined requirements is rejected at step


286


. A prefilled syringe that meets predetermined requirements is packaged at step


288


, by any suitable packaging means, inspected again at step


290


, stored at step


292


and shipped at step


294


.




The second embodiment of the process invention is depicted in the flow diagrams of

FIGS. 6



a


and


6




b


. In this embodiment, the manufacturing process takes place at separate manufacturing locations such as locations designated A, B, C and D, as shown by the dashed enclosures of

FIGS. 6



a


and


6




b


. The barrel


12


and plunger substrate


26


are molded in at least a class 100 and MCB-3 environment designated as site A in

FIG. 6



a


, by any suitable molding method such as injection molding. Plunger cover


30


and tip seal


32


are typically molded by compression molding which normally takes place in an environment less clean than a class 100 environment, designated as site B.




Referring to

FIG. 6



a


, polypropylene pellets are received at step


610


, inspected at step


612


and staged at step


614


. Similar to the molding process of

FIG. 2



a


, barrel


12


is molded at step


616


in at least a class 100 environment at a temperature sufficient to render barrel


12


substantially free from contaminants. Any particulate matter that may exist in the air proximate to the barrel


12


after the molding process is diverted away from barrel


12


by any suitable means, such as air flow. Thus, barrel


12


need not be decontaminated or otherwise washed. Barrel


12


is then inspected and packaged at step


618


. It is understood that barrel


12


may also be lubricated by any suitable means after being molded at step


616


.




In a preferred embodiment of the invention, barrel


12


is packaged according to the procedure depicted in FIG.


7


. While within a class 100 and MCB-3 environment, a plurality of barrels


12


, such as four, are placed in a holder


730




a


. Another plurality of barrels


12


, such as four, are placed in a holder


730




b


mateable with holder


730




a


to form a single clip


731


. Clip


731


along with its barrels


12


are then inserted into a first container, such as plastic bag


732




a


which is then sealed by any suitable means, such as heat sealing. A second barrel


12


and clip


731


assembly can be inserted into another first container, such as plastic bag


732




b


which is then sealed. Bags


732




a


and


732




b


are then inserted into a second container, such as plastic bag


734


, which is sealed by any suitable means, such as heat sealing. Plastic bag


734


may then be transported to an environment less clean than a class 100 environment, such as a class 10,000 environment, and inserted into a third container, such as plastic bag or carton liner


736


which is sealed by any suitable means, such as a tie or other clasp (not shown). Carton liner


736


is then inserted into a shipping container, such as container


738


which is closed for shipping. A label (not shown) may be applied to the outer surface of bags


732




a


,


732




b


,


734


and


736


to identify the contents. Further, label


740


may be applied to the outer surface of container


738


to identify the contents or provide shipping instructions. As shown in

FIG. 6



a


, after barrel


12


has been packaged at step


618


, it is shipped to site C at step


620


. It is understood that the packaging materials used to package the syringe components must themselves be substantially free from contaminants to maintain the cleanliness of the components.




Plunger substrate


26


may also be molded at site A. Polycarbonate pellets are received at step


622


, inspected at step


624


and staged at


626


. Similar to barrel


12


, plunger substrate


26


is molded at step


628


in at least a class 100 and MCB-3 environment at a temperature sufficient to render plunger substrate


26


substantially free from contaminants. Any particulate matter that may exist proximate to the plunger substrate


26


after the molding process is diverted away from plunger substrate


26


by any suitable means, such as air flow. Thus, plunger substrate


26


need not be decontaminated or otherwise washed. The molded plunger substrate


26


is then inspected and packaged at step


630


. In a preferred embodiment, plunger substrate


26


is packaged according to the packaging procedure previously described in accordance with FIG.


7


. After packaging, the plunger substrate


26


is shipped to site C at step


632


.




The plunger cover


30


is molded at site B, typically an environment less clean than a class 100 environment. As shown in

FIG. 6



a


, raw materials for the plunger cover


30


are received at step


634


. The molding compound for the cover


30


is formulated at step


636


, tested and inspected at step


638


, and staged at step


640


. Plunger cover


30


is molded at step


642


in an environment less clean than a class 100 environment, and again inspected at step


644


. To remove any contaminants that may exist on the plunger cover


30


after molding, any suitable method may be used, such as use of ultrasonic or jet washing with freon or ultra-purified water. After removing contaminants, the plunger cover


30


is maintained in a clean environment at step


649


, such as at least a class 100 environment. The inside surface of plunger cover


30


is then lubricated at step


650


using any suitable lubrication means, such as silicone, to facilitate its attachment to plunger substrate


26


. After lubrication, plunger cover


30


is packaged at step


651


in accordance with the procedure previously described in connection with

FIG. 7

, and shipped to a site C at step


652


.




Similar to plunger cover


30


, tip seal


32


is manufactured at site B. Plunger cover


30


and tip seal


32


need not be manufactured from the same materials. As shown in

FIG. 6



a


, raw materials for the tip seal


32


, are received at step


654


and the tip seal molding compound is formulated at step


656


. The tip seal compound is tested and inspected at step


658


and staged for molding at step


660


. Tip seal


32


is molded at step


662


in an environment less clean than a class 100 environment, inspected at step


664


, packaged at step


665


according to the procedure of

FIG. 7

, and shipped to site D at step


666


. It is understood that contaminants may be removed from the surface of tip seal


32


and tip seal


32


may be lubricated at site B. If so, after contaminant removal and lubrication, tip seal


32


is packaged according to the procedure previously described in accordance with

FIG. 7

, prior to shipping to site D.




At site C, plunger substrate


26


and plunger cover


30


are removed from their respective packaging at step


667


. In a preferred embodiment, these components are unpackaged according to the procedure depicted in FIG.


8


. For ex ample, packaged plunger substrates


26


are received at site C in an environment less clean than a class 100 environment, such as a class 10,000 environment, and are removed from shipping container


738


and third container or liner


736


, at steps


810


and


812


. To minimize contamination, removal from the third container takes place proximate to the feedthrough box just prior to inserting the packaged plunger substrates


26


into the feedthrough box. At step


814


, packaged plunger substrates


26


in the second container


734


are inserted into a feedthrough box connected to at least a class 100 environment, where the second container


734


is removed. After removal of the second container


734


, the packaged plunger substrates


26


within the first containers


732




a


and


732




b


are transported into the class 100 environment where the plunger substrates


26


are removed from the first containers


732




a


and


732




b


and placed into a holder (not shown), at steps


816


and


818


. The packaged plunger covers


30


are similarly unpackaged in accordance with the procedure shown in FIG.


8


.




After a plunger substrate


26


and plunger cover


30


have been unpackaged, they are assembled at step


668


to form a plunger


24


which is subsequently sterilized at step


670


, by any suitable means, such as the use of ethylene oxide. After sterilization, plunger


24


is packaged in accordance with

FIG. 7

at step


671


and then shipped to site D at step


672


.




Similarly, barrel


12


is unpackaged at site C at step


673


according to the procedure depicted in

FIG. 8

, and sterilized by any suitable means, such as the use of ethylene oxide at step


674


. Sterilized barrel


12


is then repackaged according to the procedure of

FIG. 7

at step


675


and shipped to cite D at step


676


.




Referring to

FIG. 6



b


, the plunger


24


, barrel


12


, tip seal


32


, all packaged according to the steps of FIG.


7


and unpackaged according to the steps of

FIG. 8

, and fluid


36


used to fill syringe


10


, are received at a receiving step


678


and undergo quality control inspection and testing at step


680


. Within at least a class 100 and MCB-3 environment, barrel


12


is staged at step


682


and the inside surface of barrel


12


is lubricated by any suitable lubrication means, such as silicone, at step


684


to facilitate insertion of plunger


24


. If contaminants on tip seal


32


were not previously removed at site B, tip seal


32


is placed in an environment less clean than a class 100 environment, staged at step


686


, and decontaminated at step


688


by any suitable means to remove any contaminants that may have accumulated. After decontamination, tip seal


32


is maintained in at least a class 100 and MCB-3 environment at step


690


, and then lubricated at step


692


by any suitable means, such as silicone. Tip seal


32


may also be sterilized at step


693


by any suitable method, such as use of ethylene oxide or autoclaving. The barrel


12


and tip seal


32


are then assembled to form a barrel/tip seal combination


38


at step


694


.




The fluid


36


used in syringe


10


, such as contrast medium, is staged at step


696


, made up at step


698


, put into a holding tank at step


700


, and tested at step


702


. As shown in

FIG. 6



b


, at step


704


, the barrel/tip seal combination


38


is filled with fluid


36


, preferably by the process previously described in reference to

FIGS. 3-5

. After filling, plunger


24


is inserted into the barrel/tip seal combination


38


at step


708


to complete the prefilled syringe


10


, and may be placed in a protective container. At step


710


, the prefilled syringe


10


is sterilized by any suitable method, such as autoclaving. It is understood that during autoclaving of a prefilled syringe, varying pressures are exerted on the syringe. Providing a gas overpressure during the autoclaving procedure to minimize stress on the barrel


12


to prevent plunger movement due to pressure fluctuations is known to those skilled in the art. After sterilizing, an identifying label is affixed to syringe


10


, or its protective container, at step


712


. Syringe


10


is then inspected in accordance with predetermined requirements at step


714


, and if found to be non-conforming, it is rejected at step


716


. If syringe


10


meets the predetermined requirements, it is then packaged at step


718


, inspected at step


720


, stored at step


722


and ultimately shipped at step


724


.




Alternatively, after the assembly of the barrel/tip seal combination


38


at step


694


, it is understood that the barrel/tip seal combination


38


could be packaged according to the process of

FIG. 7

, transported to at least a class 100 and MCB-3 filling and final assembly site (not shown), unpackaged according to the procedure of

FIG. 8

, and filled and finally assembled according to the procedure of

FIGS. 3-5

.




Although the manufacturing processes of the invention have been described in detail for the purpose of illustration, it is to be understood that such detail is solely for that purpose and that variations can be made thereto by those skilled in the art without departing from the spirit and scope of the invention except as it may be limited by the claims.



Claims
  • 1. A process of manufacturing a syringe, the process comprising:molding a barrel and a plunger substrate within at least a class 100 environment, without subsequently washing the barrel and the plunger substrate; packaging the barrel and plunger substrate within at least a class 100 environment, thereby maintaining the barrel and the plunger substrate substantially free of contaminants; molding a plunger cover and a tip seal within an environment less clean than a class 100 environment; packaging the plunger cover and the tip seal within at least a class 100 environment, thereby maintaining the plunger cover and the tip seal substantially free of contaminants; transporting the packaged barrel and the packaged tip seal to a first assembly site having at least a class 100 environment; unpackaging the barrel and the tip seal within the at least class 100 environment at the first assembly site; assembling the unpackaged tip seal to the unpackaged barrel within the at least class 100 environment at the first assembly site, thereby providing a barrel/tip seal combination; transporting the packaged plunger substrate and the packaged plunger cover to a second assembly site having at least a class 100 environment; unpackaging the plunger substrate and the plunger cover within the at least class 100 environment at the second assembly site; assembling the unpackaged plunger cover to the unpackaged plunger substrate within the at least class 100 environment at the second assembly site, thereby providing a plunger assembly; packaging the barrel/tip seal combination within at least a class 100 environment, thereby maintaining the barrel/tip seal combination substantially free of contaminants; packaging the plunger assembly within at least a class 100 environment, thereby maintaining the plunger assembly substantially free of contaminants; transporting the packaged barrel/tip seal combination and the packaged plunger assembly to a final assembly site having least a class 100 environment; unpackaging the barrel/tip seal combination and the plunger assembly within the at least class 100 environment at the final assembly site; and assembling the unpackaged plunger assembly to the unpackaged barrel/tip seal combination within the at least class 100 environment at the final assembly site.
  • 2. A process of manufacturing a syringe, the process comprising:molding a barrel and a plunger substrate within at least a class 100 environment; packaging the barrel and the plunger substrate within at least a class 100 environment, thereby maintaining the barrel and the plunger substrate substantially free of contaminants; molding a plunger cover and a tip seal within an environment less clean than a class 100 environment; packaging the plunger cover and the tip seal within at least a class 100 environment, thereby maintaining the plunger cover and the tip seal substantially free of contaminants; transporting the packaged barrel and the packaged tip seal to a first assembly site having at least a class 100 environment; unpackaging the barrel and the tip seal within the at least class 100 environment at the first assembly site; assembling the unpackaged tip seal to the unpackaged barrel within the at least class 100 environment at the first assembly site, thereby providing a barrel/tip seal combination; transporting the packaged plunger substrate and the packaged plunger cover to a second assembly site having at least a class 100 environment; unpackaging the plunger substrate and the plunger cover within the at least class 100 environment at the second assembly site; assembling the unpackaged plunger cover to the unpackaged plunger substrate within the at least class 100 environment at the second assembly site, thereby providing a plunger assembly; inserting each of the barrel/tip seal combination and the plunger assembly into a respective first container within at least a class 100 environment, thereby maintaining the barrel/tip seat combination and the plunger assembly substantially free of contaminants; sealing the respective first containers; inserting the respective sealed first containers into respective second containers; sealing the respective second containers; inserting the respective sealed second containers into respective third containers; sealing the respective third containers; transporting the packaged barrel/tip seal combination and the packaged plunger assembly to a final assembly site having least a class 100 environment; unpackaging the barrel/tip seal combination and the plunger assembly within the at least class 100 environment at the final assembly site; and assembling the unpackaged plunger assembly to the unpackaged barrel/tip seal combination within the at least class 100 environment at the final assembly site.
  • 3. A process of manufacturing a syringe, the process comprising:molding a barrel and a plunger substrate within at least a class 100 environment, without subsequently washing the barrel and the plunger substrate; molding a plunger cover and a tip seal within an environment less clean than a class 100 environment; inserting each of the barrel, the plunger substrate, the plunger cover and the tip seal into respective first containers within at least a class 100 environment, thereby maintaining the barrel, the plunger substrate, the plunger cover and the tip seal substantially free of contaminants; sealing the respective first containers; inserting the respective sealed first containers into respective second containers; sealing the respective second containers; inserting the respective sealed second containers into respective third containers; sealing the respective third containers; transporting the packaged barrel and the packaged tip seal to a first assembly site having at least a class 100 environment; unpackaging the barrel and the tip seal within the at least class 100 environment at the first assembly site; assembling the unpackaged tip seal to the unpackaged barrel within the at least class 100 environment at the first assembly site, thereby providing a barrel/tip seal combination; transporting the packaged plunger substrate and the packaged plunger cover to a second assembly site having at least a class 100 environment; unpackaging the plunger substrate and the plunger cover within the at least class 100 environment at the second assembly site; assembling the unpackaged plunger cover to the unpackaged plunger substrate within the at least class 100 environment at the second assembly site, thereby providing a plunger assembly; packaging the barrel/tip seal combination within at least a class 100 environment, thereby maintaining the barrel/tip seal combination substantially free of contaminants; packaging the plunger assembly within at least a class 100 environment, thereby maintaining the plunger assembly substantially free of contaminants; transporting the packaged barrel/tip seal combination and the packaged plunger assembly to a final assembly site having least a class 100 environment; unpackaging the barrel/tip seal combination and the plunger assembly within the at least class 100 environment at the final assembly site; and assembling the unpackaged plunger assembly to the unpackaged barrel/tip seal combination within the at least class 100 environment at the final assembly site.
  • 4. The process of claim 1 wherein the barrel and plunger substrate are molded within at least a MCB-3 environment.
  • 5. The process of claim 1 wherein the first assembly site is at least a MCB-3 environment.
  • 6. The process of claim 1, further comprising the steps of:prior to packaging the plunger cover and tip seal; decontaminating and lubricating the plunger cover and tip seal.
  • 7. The process of claim 1 wherein each packaging step comprises the steps of:inserting each of the barrel, plunger substrate, plunger cover and tip seal into respective first containers; sealing the respective first containers; inserting the respective sealed first containers into respective second containers; sealing the respective second containers; transporting the respective sealed second containers to an environment less clean than a class 100 environment; inserting the respective sealed second containers into respective third containers; and sealing the respective third containers.
  • 8. The process of claim 7, further comprising the steps of:prior to transporting the packaged barrel and packaged tip seal to the first assembly site, transporting the packaged barrel and packaged tip seal to a receiving site being less clean than a class 100 environment; removing each of the packaged barrel and packaged tip seal from the respective sealed third containers; transporting the packaged barrel and packaged tip seal to a feedthrough area; and removing each of the packaged barrel and packaged tip seal from the respective sealed second containers.
  • 9. The process of claim 8, further comprising the steps of:after transporting each of the packaged barrel and packaged tip seal to the first assembly site, removing each of the packaged barrel and packaged tip seal from the respective sealed first containers.
  • 10. The process of claim 7, further comprising the steps of:prior to transporting the packaged plunger substrate and packaged plunger cover to the second assembly site, transporting the packaged plunger substrate and packaged plunger cover to a receiving site being less clean than a class 100 environment; removing each of the packaged plunger substrate and packaged plunger cover from the respective sealed third containers; transporting the packaged plunger substrate and packaged plunger cover to a feedthrough area; and removing each of the packaged plunger substrate and packaged plunger cover from the respective sealed second containers.
  • 11. The process of claim 10, further comprising the step of:after transporting each of the packaged plunger substrate and packaged plunger cover to the second assembly site, removing each of the packaged plunger substrate and packaged plunger cover from the respective sealed first containers.
  • 12. The process of claim 1, further comprising the steps of:after forming the barrel/tip seal combination, packaging the barrel/tip seal combination to maintain it substantially free from contaminants; after forming the plunger, packaging the plunger to maintain it substantially free from contaminants; transporting the packaged barrel/tip seal combination and packaged plunger to a final assembly site which is at least a class 100 environment; and finally assembling the syringe by inserting the plunger into the barrel/tip seal combination to form a prefilled syringe.
  • 13. The process of claim 1 wherein the final assembly site is at least a MCB-3 environment.
  • 14. The process of claim 1 wherein the steps of packaging the barrel/tip seal combination and packaging the plunger comprise the steps of:inserting each of the barrel/tip seal combination and plunger into a respective first container; sealing the respective first containers; inserting the respective sealed first containers into respective second containers; sealing the respective second containers; transporting the respective sealed second containers to an environment less clean than a class 100 environment; inserting the respective sealed second containers into respective third containers; and sealing the respective third containers.
  • 15. The process of claim 14, further comprising the steps of:prior to final assembly of the syringe, transporting the packaged barrel/tip seal combination and packaged plunger to a receiving site being less clean than a class 100 environment; removing each of the packaged barrel/tip seal combination and packaged plunger from the respective sealed third containers; transporting each of the packaged barrel/tip seal combination and packaged plunger to a feedthrough area; and removing each of packaged barrel/tip seal combination and packaged plunger from the respective sealed second containers.
  • 16. The process of claim 15, further comprising the step of:after transporting each of the packaged barrel/tip seal combination and packaged plunger to the final assembly site, removing each of the packaged barrel/tip seal combination and packaged plunger from the respective sealed first containers.
  • 17. The process of claim 1, further comprising the step of:after final assembly of the syringe, sterilizing the prefilled syringe.
  • 18. The process of claim 2 wherein the final assembly site is at least a MCB-3 environment.
  • 19. The process of claim 2, further comprising:prior to final assembly of the syringe, transporting the packaged barrel/tip seal combination and packaged plunger to a receiving site being less clean than a class 100 environment; removing each of the packaged barrel/tip seal combination and packaged plunger from the respective sealed third containers; transporting each of the packaged barrel/tip seal combination and packaged plunger to a feedthrough area; and removing each of packaged barrel/tip seal combination and packaged plunger from the respective sealed second containers.
  • 20. The process of claim 3, further comprising:prior to transporting the packaged barrel and packaged tip seal to the first assembly site, transporting the packaged barrel and packaged tip seal to a receiving site being less clean than a class 100 environment; removing each of the packaged barrel and packaged tip seal from the respective sealed third containers; transporting the packaged barrel and packaged tip seal to a feedthrough area; and removing each of the packaged barrel and packaged tip seal from the respective sealed second containers.
  • 21. The process of claim 3, further comprising:prior to transporting the packaged plunger substrate and packaged plunger cover to the second assembly site, transporting the packaged plunger substrate and packaged plunger cover to a receiving site being less clean than a class 100 environment; removing each of the packaged plunger substrate and packaged plunger cover from the respective sealed third containers; transporting the packaged plunger substrate and packaged plunger cover to a feedthrough area; and removing each of the packaged plunger substrate and packaged plunger cover from the respective sealed second containers.
  • 22. The process of claim 1, further comprising the step of filling the assembled barrel/tip seal combination at the final assembly site with a contrast fluid.
US Referenced Citations (20)
Number Name Date Kind
3105335 Hickey Oct 1963
3202084 Hale et al. Aug 1965
3634997 Tait Jan 1972
4267769 Davis et al. May 1981
4391080 Brody et al. Jul 1983
4628969 Jurgens, Jr. Dec 1986
4660464 Tanaka Apr 1987
4677980 Reilly Jul 1987
4718463 Jurgens, Jr. Jan 1988
4880581 Dastoli et al. Nov 1989
4987673 Kogura et al. Jan 1991
5015425 Mimata et al. May 1991
5135514 Kimber Aug 1992
5141430 Maus et al. Aug 1992
5259812 Kleinsek Nov 1993
5316560 Krone-Schmidt et al. May 1994
5373757 Reilly Dec 1994
5511594 Brennan et al. Apr 1996
5535746 Hoover et al. Jul 1996
5620425 Heffernan et al. Apr 1997
Foreign Referenced Citations (4)
Number Date Country
682816 A5 Mar 1991 CH
877372 Jan 1960 GB
62-193703 Feb 1989 JP
WO9512482 May 1995 WO
Non-Patent Literature Citations (14)
Entry
“Molded Parts Discharged Without Opening The Mold”, G. Galic and S. Maus, ANTEC 1991, pp. 412-416.
“Safer Syringes Boost Molder Opportunities”, Plastics World / Aug. 1993, pp. 20-24, Carl Kirkland.
“SpritzgieBen im Reinraum”, Maschinen, Garate, Verarbeitung, Carl Hanser Verlag, Munchen 1991, Kunstostoffe 81 (1991), pp. 768-770.
“Method For The Preparation Of Pre-filled Plastic Syringe”, Request for Reexamination, Reexamination Control No. 90/004,870, Filed Dec. 12, 1997.
Clean Room Engineering p. 2,3, Clean Room Products, Inc.
Industry News, XP 000613155, PSA Sep. 1991, “Disposable Syringes: Klückner standards for mass production”, vol. 21 Jun. 1991 No. 1.
“Cleaning up with automation,” European Plastics News, vol. 21. No. 7, (Jul./Aug. 1994), p. 25.
“Clean-room Injection Moulding,” by H. Eckardt, plast europe, (Mar. 1992), pp. 54-55.
“Clean-room molding: An attractive specialty,” by Debbie Stover, Plastics Machinery& Equipment, (Feb. 1989). pp. 33-37.
“(1116) Microbiological Evaluation and Classification of Clean Rooms and Clean Zones”, Pharmacopeial Forum, vol. 18, No. 5, (Sep.-Oct. 1992), pp. 4048-4054.
Cleanroom Design, edited by W. Whyte, (1991), pp. 10, 58, 59, 128-133, 138-143, 156-157.
Federal Standard 209E Airborne Particulate Cleanliness Classes in Cleanrooms and Clean Zones, (Sep. 11, 1992), pp. 1-48.
“A Multicentred Investigation of Clean Air Requirements for Terminally Sterilized Pharmaceuticals,” by W. Whyte, Journal of Parenteral Science and Technology, vol. 37, No. 4, (Jul.-Aug. 1983), pp. 138-144.
“The Influence of Clean Room Design on Product Contamination,” by W. Whyte, Journal of Parenteral Science and Technology, vol. 38, No. 3, (May-Jun. 1984), pp. 103-108.